All terms in GO

Label Id Description
neutrophil degranulation GO_0043312
The regulated exocytosis of secretory granules containing preformed mediators such as proteases, lipases, and inflammatory mediators by a neutrophil.
inulin fructotransferase (DFA-I-forming) activity GO_0033997
Catalysis of the reaction: [(2->1)-beta-D-fructosyl](n) = [(2->1)-beta-D-fructosyl](n-1) + alpha-D-fructofuranose-beta-D-fructofuranose 1,2':1,2'-dianhydride. This reaction is the production of alpha-D-fructofuranose beta-D-fructofuranose 1,2':2,1'-dianhydride (DFA I) by successively eliminating the diminishing (2->1)-beta-D-fructan (inulin) chain from the terminal D-fructosyl-D-fructosyl disaccharide.
positive regulation of eosinophil degranulation GO_0043311
Any process that activates or increases the frequency, rate or extent of eosinophil degranulation.
positive regulation of eosinophil activation GO_1902568
Any process that activates or increases the frequency, rate or extent of eosinophil activation.
negative regulation of eosinophil degranulation GO_0043310
Any process that stops, prevents, or reduces the rate of eosinophil degranulation.
negative regulation of eosinophil activation GO_1902567
Any process that stops, prevents or reduces the frequency, rate or extent of eosinophil activation.
chondroitin B lyase activity GO_0033999
Catalysis of the reaction: dermatan sulfate = n 4-deoxy-beta-D-gluc-4-enuronosyl-(1,3)-N-acetyl-D-galactosamine 4-sulfate. This reaction is the eliminative cleavage of dermatan sulfate containing 1,4-beta-D-hexosaminyl and 1,3-beta-D-glucurosonyl or 1,3-alpha-L-iduronosyl linkages to disaccharides containing 4-deoxy-beta-D-gluc-4-enuronosyl groups to yield a 4,5-unsaturated dermatan-sulfate disaccharide (DeltaUA-GalNAC-4S). Chondroitin sulfate B is also known as dermatan sulfate.
GO_0043349 GO_0043349
GO_0043348 GO_0043348
GO_0043347 GO_0043347
N-terminal peptidyl-valine deamination GO_0018389
The deamination of the N-terminal valine residue of a protein to form isobutyrate.
N-terminal protein amino acid deamination, from amino carbon GO_0018058
The oxidative deamination of the alpha carbon of an encoded N-terminal amino acid, to form pyruvic acid retaining an amide bond between its 1-carboxyl group and the adjacent residue. The pyruvate 2-oxo group may become an enzyme active site, or it may be reduced to an alcohol.
N-terminal peptidyl-valine condensation with pyruvate to form N-pyruvic acid 2-iminyl-L-valine GO_0018388
The condensation of pyruvate through the 2-oxo group with the N-terminal valine of proteins to form the derivative N-pyruvic acid 2-iminyl-L-valine.
peptidyl-valine modification GO_0018213
The modification of peptidyl-valine.
N-terminal peptidyl-amino acid deamination to pyruvic acid GO_0018387
The oxidative deamination of N-terminal peptidyl-cysteine, or peptidyl-serine, to form pyruvic acid with an amide bond between its 1-carboxyl group and the N-terminal residue.
N-terminal peptidyl-cysteine condensation with pyruvate to form N-pyruvic acid 2-iminyl-L-cysteine GO_0018386
The condensation of pyruvate through the 2-oxo group with the N-terminal cysteine of proteins to form the derivative N-pyruvic acid 2-iminyl-L-cysteine.
GO_0018385 GO_0018385
GO_0018384 GO_0018384
GO_0018383 GO_0018383
peptidyl-lysine acetylation GO_0018394
The acetylation of peptidyl-lysine.